BioPharm International-09-01-2018

BioPharm International

FDA Seeks to Enhance Manufacturing of Cell and Gene Therapies

September 01, 2018

Regulatory Beat

31

9

More consistent and reliable production processes are critical for advancing innovative treatments.

Characterizing Critical Quality Attributes in Biopharmaceutical Drug Development

September 01, 2018

Features

31

9

Andrew Bulpin, head of Process Solutions, MilliporeSigma, shares insights on characterizing CQAs in biopharmaceutical development and the different tests that should be carried out when assessing an investigational drug.

Lightweight Actuator for Aseptic Valves

September 01, 2018

Product Spotlight

31

9

Watson-Marlow Fluid Technology Group added a new actuator suitable for applications where reduced weight is a concern.

Be a Part of the Solution

September 01, 2018

From the Editor

31

9

Sharing of bioprocessing know-how can help resolve pressing industry problems.

Checking Incoming Goods

September 01, 2018

Ask the Expert

31

9

Detailed process descriptions and robust documentation aid in compliance as well as training, says Siegfried Schmitt, principal consultant at PAREXEL.

Biopharma Demand Continues to Influence CMO Actions

September 01, 2018

Perspectives on Outsourcing

31

9

Partnerships, mergers, and new services indicate that biologics are continuing to influence CMOs’ and CDMOs’ decisions to expand their biopharmaceutical services.

USP Proposes a New Chapter for Rapid Sterility Testing

September 01, 2018

Features

31

9

The US Pharmacopeial Convention (USP) is developing a new chapter for rapid sterility testing of short-life products based on the recommendations of a panel of experts and stakeholders.

BioPharm International, September 2018 Issue (PDF)

September 01, 2018

Issue PDF

31

9

Click the title above to open the BioPharm International September 2018 issue in an interactive PDF format.